Concepedia

Chris B. Russell

CB

31

Publications

3.7K

Citations

25

H-Index

1988

Active since

Affiliations

Amgen (United States)(Current)

BioMarin (United States)

Rockefeller University

University of Oregon

University of Pennsylvania

Chris B. Russell is an author at Amgen (United States) specializing in medicine, immunology, and molecular biology.

ORCID

Top concepts

Publications per year

1988–2024

31

Publications

31

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

Kim Papp, Craig L. Leonardi, Alan Menter et al. · New England Journal of Medicine · 2012 · 923 citations

A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis

Kim Papp, Kristian Reich, C. Paul et al. · British Journal of Dermatology · 2016 · 449 citations

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A

John Pasi, Savita Rangarajan, Nina Mitchell et al. · New England Journal of Medicine · 2020 · 441 citations · Full text

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease

Stephan R. Targan, Brian G. Feagan, Séverine Vermeire et al. · The American Journal of Gastroenterology · 2016 · 360 citations

Chromosomal transformation of Escherichia coli recD strains with linearized plasmids

Chris B. Russell, David S. Thaler, Frederick W. Dahlquist · Journal of Bacteriology · 1989 · 168 citations · Full text

, , +17

Rows per page

1–5 of 31